Optiver Holding’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.94M Sell
115,761
-378,068
-77% -$16.9M ﹤0.01% 463
2026
Q1
$23.8M Buy
493,829
+150,879
+44% +$7.03M 0.01% 258
2025
Q4
$16.6M Sell
342,950
-141,339
-29% -$7.01M 0.01% 271
2025
Q3
$22.9M Sell
484,289
-8,439
-2% -$407K 0.01% 212
2025
Q2
$23.8M Buy
492,728
+356,224
+261% +$18.2M 0.01% 137
2025
Q1
$7.57M Buy
136,504
+72,899
+115% +$3.95M ﹤0.01% 189
2024
Q4
$3.07M Sell
63,605
-423,629
-87% -$21.5M ﹤0.01% 295
2024
Q3
$28.1M Buy
+487,234
New +$26.3M 0.01% 141
2023
Q4
Sell
-233,019
Closed -$12.5M 585
2023
Q3
$12.5M Sell
233,019
-483,601
-67% -$25.8M 0.01% 264
2023
Q2
$38.6M Buy
716,620
+309,649
+76% +$16.7M 0.03% 171
2023
Q1
$22.1M Buy
406,971
+302,296
+289% +$14.7M 0.02% 229
2022
Q4
$5.07M Buy
104,675
+29,736
+40% +$1.31M 0.01% 268
2022
Q3
$2.85M Buy
74,939
+700
+0.9% +$31.2K ﹤0.01% 232
2022
Q2
$3.71M Buy
+74,239
New +$3.94M ﹤0.01% 203
2022
Q1
Sell
-40,811
Closed -$2.04M 832
2021
Q4
$2.04M Buy
+40,811
New +$2.02M ﹤0.01% 219

Other funds holding SNY

Optiver Holding's SNY Position: Q2 2026 in Review

Optiver Holding reduced its Sanofi (SNY) stake by 77% in Q2 2026, selling an estimated $16.9M and leaving 115,761 shares worth $4.94M. The position accounts for ﹤0.01% of the portfolio, ranked #463.

Optiver Holding first reported a position in SNY in Q4 2021 and has held it in 15 quarters since. The position peaked at $38.6M in Q2 2023. 715 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Optiver Holding held 115,761 shares of Sanofi worth $4.94M as of Q2 2026.
  • Optiver Holding sold 378,068 Sanofi shares in Q2 2026, an estimated $16.9M.
  • Sanofi made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #463 holding.
  • Optiver Holding first reported a position in Sanofi in Q4 2021 and has held it in 15 quarters since.
  • Optiver Holding's Sanofi position peaked at $38.6M in Q2 2023.
  • 715 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.